Emerald Mutual Fund Advisers Trust Imago Bio Sciences, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$14.15 - $19.5 $367 - $507	-26 Reduced -0.0%	699,960 $10.5 Million
Q2 2022 Jul 29, 2022	BUY	$11.81 - $20.92 $2.29 Million - $4.05 Million	193,628 Added 38.24%	699,986 $9.37 Million
Q1 2022 Apr 29, 2022	SELL	$16.97 - $25.0 $577,081 - $850,150	-34,006 Reduced 6.29%	506,358 $9.76 Million
Q4 2021 Feb 02, 2022	BUY	$16.22 - $29.69 $92,778 - $169,826	5,720 Added 1.07%	540,364 $12.8 Million
Q3 2021 Oct 28, 2021	BUY	$16.0 - $28.84 $8.55 Million - $15.4 Million	534,644 New	534,644 $10.7 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.